Kenneth Cundy
Hoofd Techniek/Wetenschap/O&O bij ANEBULO PHARMACEUTICALS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Kenneth C.
Cundy is currently the Chief Scientific Officer at Anebulo Pharmaceuticals, Inc. He was previously the Chief Scientific Officer at CohBar, Inc. and the Chief Scientific Officer at XenoPort, Inc. He also worked as a Senior Director-Biopharmaceutics at Gilead Sciences, Inc. Dr. Cundy received his undergraduate degree from The University of Manchester and his doctorate from the University of Kentucky.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
29-02-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Kenneth Cundy
Bedrijven | Functie | Begin |
---|---|---|
ANEBULO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 20-05-2022 |
Eerdere bekende functies van Kenneth Cundy
Bedrijven | Functie | Einde |
---|---|---|
COHBAR, INC. | Hoofd Techniek/Wetenschap/O&O | 31-03-2022 |
XENOPORT, INC. | Corporate Officer/Principal | 01-11-2014 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-2000 |
Opleiding van Kenneth Cundy
The University of Manchester | Undergraduate Degree |
University of Kentucky | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
COHBAR, INC. | Health Technology |
ANEBULO PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |